ArticleFrontiers in neurology2025
Associations between Glasgow Coma Scale trajectories and 28-day survival rate in patients with sepsis-associated encephalopathy: insights from longitudinal group trajectory modeling.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Automated Prediction of Glasgow Coma Scale Scores From Unstructured Electronic Health Records Using Natural Language Processing: Development and Validation Study.Journal of medical Internet research · 2026Article
- Clinical Importance of the Inflammatory Prognostic Index in Patients with Sepsis.Medicina (Kaunas, Lithuania) · 2026Article
- Clinical Significance of Serum Soluble Klotho Levels in Sepsis-Associated Encephalopathy: A Single-Center Prospective, Preliminary Study.Journal of clinical medicine · 2026Article
- Early Clinical, Laboratory, and Imaging Correlates of Neurological Dysfunction in Adults Presenting to the Emergency Department with Sepsis: A Single-Center Retrospective Study.Juntendo medical journal · 2026Article
- Analysis of the prevalence and risk factors of post-intensive-care syndrome and post-sepsis syndrome in survivors of sepsis.Science progressArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sepsis-associated encephalopathy (SAE) is a common and serious complication of sepsis, characterized by altered consciousness and cognitive dysfunction. This study aimed to investigate the relationship between dynamic changes in Glasgow Coma Scale (GCS) scores during the 5 days prior to ICU admission and 28-day survive rate in patients with SAE. Patients and methods: A retrospective cohort study was conducted using data extracted from the MIMIC-IV v2.0 database. Patients diagnosed with SAE and having daily GCS measurements for 5 days prior to ICU admission were included. A total of 76,943 intensive care unit (ICU) admissions were screened, and 1,389 patients were finally analyzed. Group-based trajectory modeling (GBTM) was employed to categorize patients based on their GCS trajectories, and survival analysis was conducted using Kaplan-Meier curves and Cox regression models. Results: Four distinct GCS trajectory classes were identified: Class 1 (rapid increase), Class 2 (slow increase), Class 3 (rapid decrease), and Class 4 (persistent high level). Patients in Class 4, who had persistent high GCS scores, exhibited the highest survival rate of 82.4 ± 1.2%. In contrast, Class 1, the rapid increase group, had a survival rate of 74.1 ± 3.2%. Both Class 2 (slow increase) and Class 3 (rapid decrease) groups had lower survival rates, with Class 2 at 65.7 ± 5.7% and Class 3 at 65.2 ± 3.6% ( Conclusion: The dynamic changes in GCS scores over the 5 days prior to ICU admission was significantly associated with 28-day survive rate in patients with septic encephalopathy. Monitoring GCS fluctuations can provide valuable prognostic information in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.